217 related articles for article (PubMed ID: 31195389)
1. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
2. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
[TBL] [Abstract][Full Text] [Related]
3. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
4. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
Lobato G; Soncini CS
Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
[TBL] [Abstract][Full Text] [Related]
5. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
6. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
[TBL] [Abstract][Full Text] [Related]
7. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation.
Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA
J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors of perinatal mortality in transfused fetuses due to maternal alloimmunization: what really matters?
Osanan GC; Silveira Reis ZN; Apocalypse IG; Lopes AP; Pereira AK; da Silva Ribeiro OM; Vieira Cabral AC
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1333-7. PubMed ID: 22046976
[TBL] [Abstract][Full Text] [Related]
9. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
10. Managing the Unusual Causes of Fetal Anemia.
Maisonneuve E; Ben M'Barek I; Leblanc T; Da Costa L; Friszer S; Pernot F; Thomas P; Castaigne V; Toly N'Dour C; Mailloux A; Cortey A; Jouannic JM
Fetal Diagn Ther; 2020; 47(2):156-164. PubMed ID: 31505487
[TBL] [Abstract][Full Text] [Related]
11. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
[TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.
Klumper FJ; van Kamp IL; Vandenbussche FP; Meerman RH; Oepkes D; Scherjon SA; Eilers PH; Kanhai HH
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):91-6. PubMed ID: 10986440
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.
Kosian P; Hellmund A; Geipel A; Bald R; Geist OM; Böckenhoff P; Jimenez-Cruz J; Deja M; Strizek B; Berg C; Gembruch U
Arch Gynecol Obstet; 2023 Jul; 308(1):117-125. PubMed ID: 35916962
[TBL] [Abstract][Full Text] [Related]
14. Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are there other benefits than reducing invasive procedures?
Garabedian C; Vaast P; Behal H; Coulon C; Duahamel A; Thomas D; Rakza T; Subtil D; Houfflin-Debarge V
Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():27-30. PubMed ID: 26142913
[TBL] [Abstract][Full Text] [Related]
15. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
Gobalakichenane P; Lardennois C; Galène-Gromez S; Brossard V; Marpeau L; Verspyck E; Marret S;
Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
[TBL] [Abstract][Full Text] [Related]
16. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
17. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.
Zwiers C; Oepkes D; Lopriore E; Klumper FJ; de Haas M; van Kamp IL
Prenat Diagn; 2018 Nov; 38(12):943-950. PubMed ID: 30187936
[TBL] [Abstract][Full Text] [Related]
18. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
[TBL] [Abstract][Full Text] [Related]
19. Perinatal outcomes and survival predictors of severe red-cell alloimmunization treated by intrauterine transfusion.
Arslan E; Demir SC; Ozsurmeli M; Akcabay C
J Obstet Gynaecol Res; 2021 Aug; 47(8):2632-2640. PubMed ID: 34018269
[TBL] [Abstract][Full Text] [Related]
20. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
